Adding nivolumab to R-GemOx shows enhanced efficacy in treating R/R large B-cell lymphoma

Beat AML master trial: A clinical trial for acute myeloid leukaemia

BrECADD combined with PET2-guided treatment sets a new benchmark for the treatment of newly diagnosed advanced-stage cHL

Ponatinib is superior to imatinib in combination with chemotherapy for newly diagnosed Ph+ ALL

SABCS 2023: Latest breast cancer diagnostics guidelines

The evolving paradigm in management of Multiple Myeloma

Low-dose olanzapine after highly emetogenic chemotherapy can be the new standard of care for solid tumours

Cancer care in Needle Hospital, Hargeisa, Somaliland

Relapsed refractory multiple myeloma

The evolving paradigm in management of Multiple Myeloma

First-line chemotherapy with atezolizumab and bevacizumab significantly improves survival for R/M cervical cancer

Trial investigates multiparametric prognostic score in early HR+/HER2- breast cancer